Gefitinib vs Irbesartan

Gefitinib vs Irbesartan: Overview

This comparison examines the pharmacological differences between Gefitinib and Irbesartan.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Irbesartan — 11-15 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3; Irbesartan — C25H28N6O.

Molecular Weight: Gefitinib — 446.9000 g/mol; Irbesartan — 428.5320 g/mol.

Type: Gefitinib — Small molecule; Irbesartan — Small molecule.